We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Exact Sciences announced third-quarter revenues of $118.3 million after it screened about 241,000 people with its Cologuard at-home test for colorectal cancer—a 49% increase
Bowel cancer screening in England and Wales is to start a decade earlier in a drive to pick up more cases of the disease at an earlier stage, the government has confirmed.
HIV and syphilis screening rates are low among adolescents who are diagnosed with pelvic inflammatory disease (PID) in the emergency department, according to a study published in the August issue of Pediatrics.